Compounds > 20-hydroxy-5,8,11,14-eicosatetraenoic acid
Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and Goldblatt Syndrome

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Goldblatt Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Čertíková Chábová, V; Červenka, L; Doleželová, Š; Jíchová, Š; Kompanowska-Jezierska, E; Kopkan, L; Maxová, H; Sadowski, J; Sporková, A; Vaňourková, Z1
Carroll, MA; Chander, PN; Kang, Y; Stier, CT1
Falck, JR; Friesma, J; Kunert, MP; Lombard, JH1
Cervenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Kopkan, L; Kramer, HJ; Sporková, A; Varcabová, S1
Fava, C; Jiang, H; Lechi, A; McGiff, JC; Minuz, P; Morganti, A; Patrignani, P; Ricci, M; Tacconelli, S; Turolo, L1

Other Studies

5 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Goldblatt Syndrome

ArticleYear
Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:6

    Topics: Animals; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypertension, Renovascular; Hypolipidemic Agents; Kidney; Male; Rats; Rats, Sprague-Dawley

2017
Azilsartan is associated with increased circulating angiotensin-(1-7) levels and reduced renovascular 20-HETE levels.
    American journal of hypertension, 2015, Volume: 28, Issue:5

    Topics: Angiotensin I; Animals; Benzimidazoles; Blood Pressure; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Hypertension, Renovascular; Male; Oxadiazoles; Peptide Fragments; Rats; Rats, Sprague-Dawley; Vasoconstriction

2015
CYP450 4A inhibition attenuates O2 induced arteriolar constriction in chronic but not acute Goldblatt hypertension.
    Microvascular research, 2009, Volume: 78, Issue:3

    Topics: Amides; Animals; Arterioles; Chronic Disease; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension, Renovascular; Male; Muscle, Skeletal; Nephrectomy; Oxygen; Rats; Rats, Sprague-Dawley; Sulfones; Vasoconstriction

2009
Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Volume: 300, Issue:6

    Topics: Amidines; Animals; Arachidonic Acids; Blood Pressure; Cytochrome P-450 Enzyme System; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Hydroxyeicosatetraenoic Acids; Hypertension, Renovascular; Kidney; Male; Rats; Regional Blood Flow; Sodium

2011
Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:5

    Topics: 8,11,14-Eicosatrienoic Acid; Adult; Aged; Aged, 80 and over; Arachidonic Acid; Arachidonic Acids; Case-Control Studies; Creatinine; Cross-Sectional Studies; Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Hypertension, Renovascular; Male; Middle Aged; Renal Artery Obstruction

2008